Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,261 | 6,275 | 634 | 1,774 | 3,327 |
| TOTAL | $4,566 | $6,529 | $774 | $1,912 | $3,559 |
| Non-Current Assets | |||||
| PPE Net | 356 | 369 | 383 | 365 | 378 |
| Intangibles | 1,337 | 1,337 | 1,337 | 1,337 | 1,337 |
| Other Non-Current Assets | 3,558 | 3,072 | 3,072 | 3,133 | 3,133 |
| TOTAL | $5,251 | $4,778 | $4,791 | $4,834 | $4,847 |
| Total Assets | $9,816 | $11,307 | $5,565 | $6,746 | $8,406 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 476 | 210 | 476 | 621 | 498 |
| Accrued Expenses | 830 | 941 | 845 | 689 | 610 |
| TOTAL | $1,445 | $1,361 | $1,342 | $1,320 | $1,129 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12 | 11 | 11 | 10 | 9 |
| TOTAL | $1,222 | $1,224 | $1,226 | $1,205 | $1,205 |
| Total Liabilities | $2,666 | $2,585 | $2,567 | $2,525 | $2,334 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,781 | 1,161 | 1,152 | 1,152 | 1,144 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -35,180 | -33,288 | -27,056 | -25,432 | -23,187 |
| Other shareholders' equity | 6,086 | 6,086 | 0 | 0 | 0 |
| TOTAL | $7,150 | $8,722 | $2,997 | $4,221 | $6,072 |
| Total Liabilities And Equity | $9,816 | $11,307 | $5,565 | $6,746 | $8,406 |